{"database": "lobbying", "table": "lobbying_activities", "rows": [[1810429, "f5b46536-0fd2-42fc-b3e7-4675a59003df", "Q1", "THE PAUL LAXALT GROUP", 22325, "THE ROGOSIN INSTITUTE", 2016, "first_quarter", "MED", "The Chronic Kidney Disease Improvement in Research and Treatment Act S.598 H.R.1130.", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2016-04-18T11:25:01.933000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1810429"], "units": {}, "query_ms": 0.44440999772632495, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}